Diagnostic Role of N-Acetyl-β-D-Glucosaminidase as an Early Marker of Kidney Damage

O.O. Melnyk

Abstract


In many diseases of the kidneys, N-acetyl-β-D-glucosaminidase (NAG) in the urine is excreted in large quantities. A significant increase in NAG activity is observed at the primary and secondary kidney damage, heavy metal poisoning, kidney transplantation, kidney tumor, hypertension, preeclampsia in pregnant women, diabetic nephropathy, polycystic kidneys, glomerulonephritis. Commercial kits have been developed to measure the activity of NAG c using a colorimetric (biochemical) and enzyme-linked immunosorbent (ELISA) methods of research.


Keywords


increased activity of N-acetyl-β-D-glucosaminidase in the urine; diabetic nephropathy; polycystic kidneys; preeclampsia in pregnant women; glomerulonephritis, colorimetric and enzyme immunoassay methods for determining urinary NAG

References


Kolesnikov S.V., Borisov А.S. Biomarkery ostrogo pochechnogo povrejdeniya: klinicheskii aspecty // Nephrologia i dialys. — 2013. — ​Т. 15, № 3. — ​С. 184-190.

Devarajan P. Biomarkers for the Early Detection of Acute Kidney Injury // Curr. Opin. Pediatr. — 2011 April. — ​Vol. 23(2). — ​Р. 194-200.

Geus H., Betjes M., Bakker J. Biomarkers for the prediction of acute kidney injury: a narrative review on current status and future challenges // Clin. Kidney J. — 2012. — ​Vol. 5. — № 2. — ​

P. 102-108.

Bosomworth M.P., Aparicio S.R., Hay A.W. Urine ­N-acetyl-β-D glucosaminidase — ​а marker of tubular damage? // Nephrol. Dial. Transplant. — 1999. — ​620-626.

Skálová S. The diagnostic role of urinary N-acetyl-β-D-glucosaminidase (NAG) activity in the detection of renal tubular impairment / S. Skálová // Acta Medica. — 2005. — ​Vol. 48. — ​P. 75-80.

Liangos O., Perianayagan M.C., Vaidya V.S. et al. Urinary N-acetylbeta-(D) — ​glucosaminidase activity and kidney injury mo­lecule‑1 level are associated with adheres outcomes in acute renal fai­lure // J. Am. Soc. Nephrol. — 2007. — 18(3). — 904-912.

Mohkam M. The Role of Urinary N-acetyl-beta-glucosami­nidase in Diagnosis of Kidney Diseases / M. Mohkam, A. Ghafari // J. Ped. Nephrology. — 2015. — ​Vol. 3. — ​P. 84-91.

Assay of Urinary N-Acetyl-β-glucosaminidase in a Centrifugal Analyzer Powell / C. Samuel, J. Scaro, E. Wilson, Z.K. Shihabi // Clin. Chem. — 1983. — ​Vol. 29. — ​P. 1717-1719.

Li J., Li Q.X., Xie X.F. et al. Differential roles of dihydropyridine calcium antagonist nifedipine, nitrendipine and amlodipine on gentamicininduced renal tubular toxicity in rats // Eur. J. Pharmacol. — 2009. — 620. — 97-104.

Xu Z., Yang J., Yu J. et al. Effects of BSO, GSH, Vit-C and DMPS on the nephrotoxicity of mercury // Toxicol. Ind. Health. — 2007. — 23. — 403-410.

Ali B.H., Al Moundhri M.S., Tag Eldin M. et al. The ameliorative effect of cysteine prodrug L‑2-oxothiazolidine‑4-carboxylic acid on cisplatininduced nephrotoxicity in rats // Fundam. Clin. Pharmacol. — 2007. — 21. — 547-553.

Westhuyzen J., Endre Z.H., Reece G. et al. Measurement of tubular enzymuria facilitates early detection of acute renal impairment in the intensive care unit // Nephrol. Dial. Transplant. — 2003. — 18. — 543-551.

Bondiou M.T., Bourbouze R., Bernard M. et al. Inhibition of A and B N-acetyl-beta-D-glucosaminidase urinary isoenzymes by urea // Clin. Chim. Acta. — 1985. — 149. — 67-73.

Vaidya V.S., Ramirez V., Ichimura T. et al. Urinary kidney injury molecule1 (Kim‑1): a sensitive quantitative biomarker for early detection of kidney tubular injury // Am. J. Physiol. Renal. Physiol. — 2005.

Price R. The role of NAG (N-acetyl-beta-d-glucosaminidase) in the diagnosis of kidney disease including the monitoring of nephrotoxicity // Clin. Nephrol. — 1992. — ​Vol. 38. — ​P. 14-19.

Zheng J., Xiao Y., Yao Y. et al. Comparison of urinary biomarkers for early detection of acute kidney injury after cardiopulmonary bypass surgery in infants and young children // Pediatr. Car­diol. — 2013. — ​Vol. 34, № 4. — ​P. 880-886.

Damman K., Masson S., Hillege H.L. et al. Tubular damage and worsening renal function in chronic heart failure // JACC Heart Fail. — 2013. — ​Vol. 1, № 5. — ​P. 417-424.

Marchewka Z., Kuzniar J., Dlugosz A. Enzymuria and beta‑2-microglobulinuria in the assessment of the influence of protei­nuria on the progression of glomerulopathies // Int. Urol. Nephrol. — 2001. — ​Vol. 33. — ​P. 673-676.

Mogensen C.E., Christensen C.K. Predicting diabetic nephropathy in insulin-dependent patients // N. Engl. J. Med. — 1984. — 311(2). — 89-93.

Mogensen C.E. Microalbuminuria predicts clinical proteinuria and early mortality in maturityonset diabetes // N. Engl. J. Med. — 1984. — 310(6). — 356-360.

Rocco M.V., Berns J.S. KDOQI in the era of global guidelines // Am. J. Kidney Dis. — 2009. — 54(5). — 781-787.

Vaidya V.S. et al. Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomar­kers, kidney injury molecule‑1, and N-acetyl-β-D-glucosaminidase // Kidney Int. — 2011. — 79(4). — 464-470.

Mottl A.K., Kwon K.S., Mauer M., Mayer-Davis E.J., Hogan S.L., Kshirsagar A.V. Normoalbuminuric diabetic kidney di­sease in the U.S. population // J. Diabetes Complications. — 2013. — 27(2). — 123-127.

Perkins B.A., Ficociello L.H., Silva K.H., Finkelstein D.M., Warram J.H., Krolewski A.S. Regression of microalbuminuria in type 1 diabetes // N. Engl. J. Med. — 2003. — 348(23). — 2285-2293.

Шестакова М.В. Современное понятие «хроническая болезнь почек»: методы диагностики, клиническое значение // Сахарный диабет. — 2008. — 2. — 4-7.

Pedersen M.M., Christiansen J.S., Pedersen E.B., Mogensen C.E. Determinants of intraindividual variation in kidney function in normoalbuminuric insulin-dependent diabetic patients: importance of atrial natriuretic peptide and glycaemic control // Clin. Sci. — 1992. — 83. — 445-51.

Kania K., Byrnes E.A., Beilby J.P., Webb S.A., Strong K.J. Urinary proteases degrade albumin: implications for measurement of albuminuria in stored samples // Ann. Clin. Biochem. — 2010. — 47(Pt 2). — 151-7.

Dedov I.I., Shestakov M.V. Saharniy diabet i chronicheskaya bolezn pochek. — ​М.: Meditsinskoye informatsionnoe agentstvo, 2009. — 482 с.

Nauta F.L., Boertien W.E., Bakker S.J., van Goor H., van Oeveren W., de Jong P.E., Bilo H., Gansevoort R.T. Glomerular and tubular damage markers are elevated in patients with diabetes // Diabetes Care. — 2011 Apr. — 34(4). — 975-981. [Epub 2011 Feb 9]

Vaidya V.S., Niewczas M.A., Ficociello L.H., Johnson A.C., Collings F.B., Warram J.H., Krolewski A.S., Bonventre J.V. Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule‑1, and N-acetyl-β-D-glucosaminidase // Kidney Int. — 2011 Feb. — 79(4). — 464-470. [Epub 2010 Oct 27]

Kern E.F., Erhard P., Sun W., Genuth S., Weiss M.F. Early Urinary Markers of Diabetic Kidney Disease: A Nested Case-Control Study From the Diabetes Control and Complications Trial (DCCT) // Am. J. Kidney Dis. — 2010 May. — 55(5). — 824-834.

Mohammadi-Karakani A., Asgharzadeh-Haghighi S., Ghazi-Khansari M., Hosseini R. Determination of urinary enzymes as a marker of early renal damage in diabetic patients // J. Clin. Lab. Anal. — 2007. — 21(6). — 413-417.

Sheira G., Noreldin N., Tamer A., Saad M. Urinary biomarker N-acetyl-β-D-glucosaminidase can predict severity of renal damage in diabetic nephropathyм // Journal of Diabetes & Metabolic Disorders. — 12 February 2015. — 14. — 4.

Kaneko K., Chiba M., Hashizume M., Kunii O., Sasaki S., Shimoda T. et al. Renal tubular dysfunction in children living in the Aral Sea Region // Arch. Dis. Cild. — 2003. — 88. — 966-8.

Abdel Shakour S., Hefnawy H., Yamani M., Azmi Y. Urinary N-acetyl-beta-D-glucosaminidase in children with diabetes as an early marker of diabetic nephropathy // East Mediterr. Health J. — 2002. — 8. — 24-30.

Kuźniar J., Marchewka Z., Lembas-Bogaczyk J., Kuźniar T.J., Klinger M. Etiology of increased enzymuria in diffe­rent morphological forms of glomerulonephritis // Nephron. Physiol. — 2004. — 98. — 8-14.

Navarro J.F., Mora C., Muros M., Maca M., Garca J. Effects of pentoxifylline administration on urinary N-acetyl-beta-glucosaminidase excretion in type 2 diabetic patients: a short-term, prospective, randomized study // Am. J. Kidney Dis. — 2003. — 422. —

-70.

Nauta F., Bakker S., Oeveren W., Navis G., van der Heide J.J., van Goor H. et al. Albuminuria, proteinuria, and novel urine biomarkers as predictors of long-term allograft outcomes in kidney transplant recipients // Am. J. Kidney Dis. — 2011. — 57. —

-43.

Bouvet B.R., Paparella C.V., Arriaga S., Monje A.L., Amarilla A.M., Adriana M. Almará1 A. Evaluation of urinary N-acetyl-beta-D-glucosaminidase as a marker of early renal damage in patients with type 2 diabetes mellitus // Arq. Bras. Endocrinol. Metab. — 2014. — 58/8. — 798-801.

Nauta F.L., Boertien W.E., Bakker S.J., van Goor H., van Oeveren W., de Jong P.E. et al. Glomerular and tubular damage markers are elevated in patients with diabetes // Diabetes Care. — 2011. — 34. — 975-81.

Piwowar A., Knapik-Kordecka M., Fus I., Warwas M. Urinary activities of cathepsin B, N-acetyl-beta-D-glucosaminidase, and albuminuria in patients with type 2 diabetes mellitus // Med. Sci. Monit. — 2006. — 12. — ​CR210-14.

Udomah F.P., Ekpenyong Ekrikpo U., Effa E., Salako B., Arije A., Kadiri S. Association between Urinary N-Acetyl-Beta-D-Glucosaminidase and Microalbuminuria in Diabetic Black Africans // Int. J. Nephrol. — 2012. — 235234.

Kim S.R, Lee Yong-ho, Lee Sang-Guk, Eun Seok Kang, Bong-Soo Cha, Kim Jeong-Ho, Lee Byung-Wan. Urinary N-acetyl-b-D-glucosaminidase, an early marker of diabetic kidney disease, might reflect glucose excursion in patients with type 2 diabetes // Medicine. — 2016. — 95. — 27. — ​Р. 1-8.

Fu W.J., Xiong S.L., Fang Y.G. et al. Urinary tubular biomarkers in shortterm type 2 diabetes mellitus patients: a cross-sectional study // Endocrine. — 2012. — 41. — 82-8.

Nauta F.L., Boertien W.E., Bakker S.J. et al. Glomerular and tubular damage markers are elevated in patients with diabetes // Diabetes Care. — 2011. — 34. — 975-81.

Patel D.N., Kalia K. Efficacy of urinary N-acetyl-b-D-glucosaminidase to evaluate early renal tubular damage as a consequence of type 2 diabetes mellitus: a cross-sectional study // Int. J. Diabetes Developing Countries. — 2015. — 35. — 449-57.

Sheira G., Noreldin N., Tamer A. et al. Urinary biomarker ­N-acetyl-beta-D-glucosaminidase can predict severity of renal da­mage in diabetic nephropathy // J. Diabetes Metab. Disord. — 2015. — 14. — 4.

Tanaka A., Shima K., Fukuda M. et al. Tubular dysfunction in the early stage of diabetic nephropathy // Med. J. Osaka Univ. — 1989. — 38. — 57-63.

Grantham J.J., Torres V.E., Chapman A.B., Guay-Woodford L.M., Bae K.T., King B.F. Jr, Wetzel L.H., Baumgarten D.A., Kenney P.J., Harris P.C., Klahr S., Bennett W.M., Hirschman G.N., Meyers C.M., Zhang X., Zhu F., Miller J.P., CRISP Investigators: Volume progression in polycystic kidney disease // N. Engl. J. Med. — 2006. — 354. — 2122-2130.

Serra A.L., Kistler A.D., Poster D., Struker M., Wuthrich R.P., Weishaupt D., Tschirch F. Clinical proof-of-concept trial to assess the therapeutic effect of sirolimus in patients with autosomal dominant polycystic kidney disease: SUISSE ADPKD study // BMC Nephrol. — 2007. — 8. — 13.

Park H.C., Hwang J.H., Kang Ah-Young et al. Urinary N-acetyl-β-D glucosaminidase as a surrogate marker for renal function in autosomal dominant polycystic kidney disease: 1 year prospective cohort study? // BMC Nephrology. — 2012. — 13. — 93.

Hultberg B., Isaksson A., Krutzen E., Nilsson-Ehle P. Urinary Excretion of N-Acetyl-β-D-glucosaminidase in Normal and Complicated Pregnancy // J. Clin. Chem. Clin. Biochem. — 1989. — ​Vol. 27. — ​P. 487-489.

Semczuk-Sikora A., Sikora P., Semczuk M., Biadun U. Urinary N-acetyl-beta-D-glucosaminidase (NAG) excretion in women with pregnancy complicated with hypertension // Ginekol. Pol. — 2003. — ​Vol. 74. — ​P. 1269-1275.

Jacob M., Wilfred G., Kanagasabapathy A.S., Balasubramaniam N. Urinary N-Acetyl-β-D-glucosaminidase in the Prediction of Preeclampsia and Pregnancy-induced Hypertension // ANZJOG. — 2008. — ​Vol. 10. — ​P. 28-31.

Bazzi C., Pctrini C., Rizza V., Arrigo G., Napodano P., Paparella M. et al. Urinary N-acetyl-beta-Dglucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis // Nephrol. Dial. Transplant. — 2002. — 17. — 1890-6.

Orfeas L., Mary C., Vishal S. et al. (Urinary N-Acetyl-(D)-Glucosaminidase activity and kidney injury molecule‑1 level are associated with adverse outcomes in acute renal failure // J. Am. Soc. Nephrol. — 2007. — 18. — 904-12.




DOI: https://doi.org/10.22141/2307-1257.0.4.18.2016.84327

Refbacks

  • There are currently no refbacks.


Copyright (c) 2016 KIDNEYS

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© "Publishing House "Zaslavsky", 1997-2017

 

 Яндекс.МетрикаSeo анализ сайта Рейтинг@Mail.ru